CastleKnight Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.34M Buy
1,389,633
+424,200
+44% +$2.71M 0.1% 145
2026
Q1
$7.03M Buy
965,433
+120,700
+14% +$1.09M 0.12% 117
2025
Q4
$8.13M Buy
844,733
+25,200
+3% +$261K 0.18% 75
2025
Q3
$9.99M Sell
819,533
-71,228
-8% -$748K 0.2% 72
2025
Q2
$7.12M Buy
890,761
+512,500
+135% +$3.6M 0.2% 87
2025
Q1
$2.75M Buy
378,261
+299,361
+379% +$2.18M 0.11% 118
2024
Q4
$544K Sell
78,900
-50,800
-39% -$349K 0.02% 304
2024
Q3
$956K Buy
+129,700
New +$1.21M 0.04% 221

Other funds holding NUS

CastleKnight Management's NUS Position: Q2 2026 in Review

CastleKnight Management increased its Nu Skin (NUS) stake by 44% in Q2 2026, buying an estimated $2.71M and bringing the position to 1,389,633 shares worth $7.34M. The position accounts for 0.1% of the portfolio, ranked #145.

CastleKnight Management first reported a position in NUS in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.99M in Q3 2025. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • CastleKnight Management held 1,389,633 shares of Nu Skin worth $7.34M as of Q2 2026.
  • CastleKnight Management bought 424,200 Nu Skin shares in Q2 2026, an estimated $2.71M.
  • Nu Skin made up 0.1% of CastleKnight Management's portfolio in Q2 2026, its #145 holding.
  • CastleKnight Management first reported a position in Nu Skin in Q3 2024 and has held it in 8 quarters since.
  • CastleKnight Management's Nu Skin position peaked at $9.99M in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.